Research Papers

22 of 522 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bactera…
Moise PA; Smyth DS; Robinson DA; El-Fawal N; McCalla C; Sakoulas G.
J Antimicrob Chemother (Unknown)
Published: 2009
1/6 Transparent
Funding Declared
Indigenous evolution of Plasmodium falciparum pyrimethamine resistance multiple times in Africa.
Mita T; Tanabe K; Takahashi N; Culleton R; Ndounga M; Dzodzomenyo M; Akhwale WS; Kaneko A; Kobayakawa T.
J Antimicrob Chemother (Unknown)
Published: 2008
1/6 Transparent
Funding Declared
Development and assessment of a new early scoring system using non-specific clinical signs and biological results to id…
Richet H; Casalta JP; Thuny F; Mérrien J; Harlé JR; Weiller PJ; Habib G; Raoult D.
J Antimicrob Chemother (Unknown)
Published: 2008
2/6 Transparent
Funding Declared
Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element.
Opintan JA; Newman MJ; Nsiah-Poodoh OA; Okeke IN.
J Antimicrob Chemother (Unknown)
Published: 2008
1/6 Transparent
Funding Declared
Transfer of antimicrobial resistance plasmids from Klebsiella pneumoniae to Escherichia coli in the mouse intestine.
Schjørring S; Struve C; Krogfelt KA.
J Antimicrob Chemother (Unknown)
Published: 2008
1/6 Transparent
Funding Declared
In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum.
Klein P; Cirioni O; Giacometti A; Scalise G.
J Antimicrob Chemother (Unknown)
Published: 2008
1/6 Transparent
Funding Declared
Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 v…
Stein DA; Huang CY; Silengo S; Amantana A; Crumley S; Blouch RE; Iversen PL; Kinney RM.
J Antimicrob Chemother (Unknown)
Published: 2008
1/6 Transparent
Funding Declared
The management of coronavirus infections with particular reference to SARS.
Wong SS; Yuen KY.
J Antimicrob Chemother (Unknown)
Published: 2008
Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cult…
Barcia-Macay M; Mouaden F; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F.
J Antimicrob Chemother (Unknown)
Published: 2008
1/6 Transparent
Funding Declared
Microbiological evaluation of a new growth-based approach for rapid detection of methicillin-resistant Staphylococcus a…
von Eiff C; Maas D; Sander G; Friedrich AW; Peters G; Becker K.
J Antimicrob Chemother (Unknown)
Published: 2008
1/6 Transparent
Funding Declared
The carbohydrate-binding plant lectins and the non-peptidic antibiotic pradimicin A target the glycans of the coronavir…
van der Meer FJ; de Haan CA; Schuurman NM; Haijema BJ; Verheije MH; Bosch BJ; Balzarini J; Egberink HF.
J Antimicrob Chemother (Unknown)
Published: 2007
1/6 Transparent
Funding Declared
The state of play in the battle against antimicrobial resistance: a general practitioner perspective.
Fleming DM.
J Antimicrob Chemother (Unknown)
Published: 2007
Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell cul…
Balzarini J; Keyaerts E; Vijgen L; Vandermeer F; Stevens M; De Clercq E; Egberink H; Van Ranst M.
J Antimicrob Chemother (Unknown)
Published: 2005
2/6 Transparent
Funding Declared
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hosp…
Yeh KM; Chiueh TS; Siu LK; Lin JC; Chan PK; Peng MY; Wan HL; Chen JH; Hu BS; Perng CL; Lu JJ; Chang FY.
J Antimicrob Chemother (Unknown)
Published: 2005
1/6 Transparent
A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community.
Oxford J; Balasingam S; Lambkin R.
J Antimicrob Chemother (Unknown)
Published: 2003
Ribavirin, viramidine and adenosine-deaminase-catalysed drug activation: implication for nucleoside prodrug design.
Wu JZ; Lin CC; Hong Z.
J Antimicrob Chemother (Unknown)
Published: 2003
New treatments for viral respiratory tract infections--opportunities and problems.
Snell NJ.
J Antimicrob Chemother (Unknown)
Published: 2001
The clinical evaluation of antiviral agents. Report of a Working Party of the British Society for Antimicrobial Chemoth…
NA
J Antimicrob Chemother (Unknown)
Published: 1997
Drugs against rhinoviruses.
al-Nakib W; Tyrrell DA.
J Antimicrob Chemother (Unknown)
Published: 1992
Activity of glucosidase inhibitors against HIV infections.
Tyms AS; Taylor DL.
J Antimicrob Chemother (Unknown)
Published: 1988
Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges.
Al-Nakib W; Higgins PG; Barrow I; Batstone G; Tyrrell DA.
J Antimicrob Chemother (Unknown)
Published: 1987
Travellers' diarrhoea.
James DG.
J Antimicrob Chemother (Unknown)
Published: 1977